| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113883.3.1444.3.223 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.223/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223 |
| Version | 20250409 |
| Status | active |
| Date | 2025-04-09T01:09:28-04:00 |
| Name | ModerateEmeticRiskIntravenousAntineoplasticAgent |
| Title | Moderate Emetic Risk Intravenous Antineoplastic Agent |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of moderate emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a moderate emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
FHIR